Metronomic weekly paclitaxel in advanced unresectable esophageal cancer.

Noronha, V; Patil, V; Bhosale, B; Joshi, A; Purandare, N; Prabhash, K

Noronha, V; Patil, V; Bhosale, B; Joshi, A; Purandare, N; Prabhash, K.

Indian J Cancer ; 2013 Apr-June; 50(2): 128-134

Article in En | IMSEAR | ID: sea-148637

Subject(s)

Administration, Metronomic; Adult; Aged; Carcinoma, Squamous Cell/drug therapy; Carcinoma, Squamous Cell/pathology; Cisplatin/administration & dosage; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions/pathology; Esophageal Neoplasms/drug therapy; Esophageal Neoplasms/pathology; Female; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel/administration & dosage; Paclitaxel/adverse effects

Key words

Chemotherapy; esophageal neoplasms; esophagogastric junction; esophagus; metronomic; paclitaxel; palliative

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: IMSEAR Main subject: Aged / Female / Humans / Male / Esophageal Neoplasms / Carcinoma, Squamous Cell / Cisplatin / Paclitaxel / Disease-Free Survival / Adult Language: En Journal: Indian J Cancer Year: 2013 Type: Article

Fulltext

Add to My VHL

XML

Search on Google